Xtant Medical Holdings, Inc. (XTNT)

Market Cap	57.27M
Revenue (ttm)	113.86M
Net Income (ttm)	-17.59M
Shares Out	139.01M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	175,839
Open	0.426
Previous Close	0.430
Day's Range	0.394 - 0.447
52-Week Range	0.394 - 1.450
Beta	0.38
Analysts	Strong Buy
Price Target	3.00 (+628.16%)
Earnings Date	Nov 12, 2024

About XTNT

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the oste...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Sean Browne
• Employees: 215
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: XTNT
• Website: https://www.xtantmedical.com

Analyst Forecast

According to one analyst, the rating for XTNT stock is "Strong Buy" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(628.16% upside)

Analyst Consensus: Strong Buy